Navigation Links
Volcano Corporation Provides Additional Guidance For 2013
Date:2/21/2013

SAN DIEGO, Feb. 21, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, is providing additional guidance for 2013 on an as reported basis to augment guidance provided on a constant currency basis in its fourth quarter 2012 earnings news release earlier today.

On an as reported basis, based on foreign currency exchange rates as of February 21, 2013, the company expects revenues will be in the range of $406-$412 million in 2013. Earlier today, the company provided guidance for revenues in 2013 in the range of $422-$428 million on a constant currency basis.

On an as reported basis, Volcano expects gross margins will be in the range of 65.0-65.5 percent and operating expenses will be 62-63 percent of revenues. On a reported basis, the company expects a net loss on a GAAP basis of $0.19-$0.23 per share, including an expected tax benefit of approximately $4.8 million. On a reported basis, the company expects non-GAAP net income of $0.08-$0.11 per diluted share in 2013. Non-GAAP results exclude acquisition-related expenses, amortization of intangibles and non-cash interest expense, and assume an effective tax rate of 38 percent for the GAAP to non-GAAP adjustments. The company expects weighted average basic shares in 2013 will be approximately 54.4 million shares and approximately 56.2 million shares on a diluted basis.

About Volcano

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using sound and light a
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Volcano Announces Record Fourth Quarter Revenues
2. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
3. Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
4. Volcano Corporation To Offer $350 Million Convertible Senior Notes Due 2017
5. Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
6. Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast
7. Fish & Richardson Prevails in Patent Infringement Trial for Volcano Corporation
8. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
9. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
10. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
11. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... MELBOURNE, Australia and BARCELONA , ... Pty Ltd (Multigate) was found to infringe two Australian patents ... offering for sale in Australia safety ... of 17.10.14 in Federal Court of Australia ... at http://www.austlii.edu.au/au/cases/cth/FCA/2014/1110.html . In the detailed ...
(Date:10/31/2014)... 2014 Electronic prescribing or E-Prescribing ... prescription related information between prescriber, dispenser and ... physician and nurse practitioner to transmit a ... occurs during pharmacy operations. E-Prescribing system has ... complete medical lists, conducts all security checks ...
(Date:10/30/2014)... , Oct. 30, 2014 /CNW/ - Atlantic Canadians will ... reached between Canada,s provinces and ... , President of the Canadian Generic Pharmaceutical Association (CGPA), ... comments while speaking at the Atlantic Summit on Healthcare ... , which is being hosted by the Public Policy ...
Breaking Medicine Technology:B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3
... 2011 Varian Medical Systems (NYSE: VAR ... cancer treatment technologies at the upcoming American Urological Association ... will sponsor a series of presentations covering emerging treatments ... Within the company,s exhibit, Varian will showcase its latest ...
... May 11, 2011 ViroPharma Incorporated (Nasdaq: ... today that Halozyme has granted ViroPharma an exclusive ... a proprietary drug delivery platform using Halozyme,s recombinant ... a C1 esterase inhibitor. Additionally, Halozyme has agreed not ...
Cached Medicine Technology:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Approaches at the American Urological Association Meeting in Washington, D.C. 2Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Approaches at the American Urological Association Meeting in Washington, D.C. 3ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 2ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 3ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 4ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 5ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 6ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor 7
(Date:10/31/2014)... 31, 2014 FindSurrogateMother.com conveys ... gifts of life — building a family through surrogacy. ... mothers and donors with hopeful intended parents in turn ... , It’s a collective aptitude of surrogate mothers, intended ... and fertility clinics that help provide these connections — ...
(Date:10/31/2014)... Phoenix dentist , Dr. Christy, is now offering 10 ... need routine care or have a more in-depth dental health ... that necessary care. The right dental treatments can transform a ... treatments due to financial concerns. Throughout the month of November, ... by the team at Christy Dental Care. , According ...
(Date:10/31/2014)... Radiology and EMR Integration , “Surveys ... diagnostic imaging centers but Connectivity is Opportunity,” says ... “Differentiation is critical in all businesses today and ... the intense competition and the downward pressure on ... from the competition by fully integrating with the ...
(Date:10/31/2014)... -- A few simple steps can help make this weekend,s ... "Adjusting to the end of Daylight Saving Time in ... change in the spring. The main reason is because we ... Dr. Praveen Rudraraju, director of the Center for Sleep Medicine ... a hospital news release. The many Americans who are ...
(Date:10/31/2014)... By Dennis Thompson ... (HealthDay News) -- A full-court press involving all public ... required to quell the current West African epidemic, a ... burying the Ebola-infected dead in a hygienic way, immediately ... virus, and providing better protection for health care workers ...
Breaking Medicine News(10 mins):Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2Health News:Make the Most of This Weekend's Time Change 2Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 2Health News:4 Steps Could Quell Ebola in West Africa, Researchers Say 3
... GREENVILLE, SC, Oct. 17 /PRNewswire/ - The numbers are ... developing countries have a,disability. "It,s not the impairment ... disabilities, but their exclusion from mainstream,social, economic and political ... "We have to work together to stand up ...
... Oct. 16 Children in the South Bay,suffering ... conditions can,now receive specialty care from Lucile Packard ... hospital,s new South Bay,Specialty Center in Los Gatos ... all the hallmarks of its parent institution. ...
... Oct. 16 AtriCure, Inc.,(Nasdaq: ATRC ), ... surgical,ablation products, today announced that results reporting on ... adopted to,treat atrial fibrillation (AF), were published in ... McClelland, an,electrophysiologist, and colleagues from the Oregon Heart ...
... Oct. 16 At the U.S. Food ... Advisory Committee,meeting today, the majority of members ... including Shire Pharmaceuticals, non-calcium FOSRENOL(R),(lanthanum carbonate), to ... blood) in chronic kidney disease (CKD) Stage ...
... Multi-Year Search and Advertising ... Distribution Agreements, WebMD Announces Third ... 16 WebMD Health Corp. (Nasdaq:,WBMD), the leading provider of health ... September 30,2007. Preliminary Results for the Three Months Ended September ...
... PARK, N.J., Oct. 16 HLTH Corporation,(Nasdaq: HLTH ... for,the three months ended September 30, 2007 at approximately ... addition, as previously announced, HLTH Corporation,s 84% owned,subsidiary, WebMD ... will also,release their financial results for the three months ...
Cached Medicine News:Health News:CBM USA stands up and speaks out to world leaders on the International Day for the Eradication of Poverty 2Health News:Packard Children's Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 2Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 3Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 4Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 5Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 6Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 7Health News:WebMD Reports Preliminary Third Quarter Financial Results 2Health News:WebMD Reports Preliminary Third Quarter Financial Results 3Health News:WebMD Reports Preliminary Third Quarter Financial Results 4Health News:WebMD Reports Preliminary Third Quarter Financial Results 5Health News:WebMD Reports Preliminary Third Quarter Financial Results 6Health News:WebMD Reports Preliminary Third Quarter Financial Results 7Health News:WebMD Reports Preliminary Third Quarter Financial Results 8Health News:WebMD Reports Preliminary Third Quarter Financial Results 9Health News:WebMD Reports Preliminary Third Quarter Financial Results 10Health News:WebMD Reports Preliminary Third Quarter Financial Results 11Health News:HLTH Corporation Announces Third Quarter Earnings Release Date and Conference Call 2
... for optimum patient comfort. The Nylon Finger Trap ... firm grip. ISI Nylon Finger Traps create a ... with the ISI Digi Grip or ISI Advanced ... available in non-sterile packs and come in five ...
... The CMIS Telemetry System is a ... of hospitals which require monitoring and ... facilities are able to monitor patients ... ambulatory transmitters and wireless bedsides. Now, ...
ISI Self-Supporting Arm Table offers the easy accessibility for surgeons, technicians and equipment during upper extremity surgeries....
MagPrep® Streptavidin Beads are encapsulated super-paramagnetic polystyrol particles coated with streptavidin. The beads have a diameter of 1 m and are provided as a stabilized aqueous suspensio...
Medicine Products: